After years of distributing ethical medicines from different companies, the business is preparing to establish its own pharmaceutical venture and introduce an own portfolio of products
Viral Shah, Managing Partner, Hardik Jain, Partner
In pharmaceutical distribution, access to a medicine does not necessarily create an advantage. A pharmaceutical company may have 10, 20 or even 40 stockists serving the same market, often supplying the same brands at largely comparable prices. The real contest, therefore, is over reliability: who does a chemist call first, which distributor can source with confidence, and who will respond when the requirement is urgent rather than routine?
Kunthunath Medical Agency has built its business around this reality. Emerging from Surat and drawing on experience developed across Maharashtra and Gujarat, the firm is expanding towards a PAN-India distribution network for ethical medicines. Instead of treating scale as simply adding territories and customers, it has concentrated on three areas that become harder to preserve as a distributor grows: knowing the source of its products, developing relationships beyond individual transactions, and ensuring expansion does not outpace service capability.
Behind this approach is Viral Shah, who entered pharmaceutical distribution while still in college. A B.Com graduate from Veer Narmad South Gujarat University, Shah spent three years learning the trade at Kailash Pharma and his mentor was Sanjay Rathod. The experience gave him something more valuable than a theoretical understanding of the sector: exposure to how the distribution market actually behaves.
Taking a Mumbai Learning Curve Back to Surat
Shah's formative experience came in Maharashtra, particularly within the demanding Mumbai market. Returning to Surat meant that he could not simply replicate an existing network. He had to understand another city's buying behaviour, establish credibility locally and build relationships afresh.
The transition also revealed an important feature of pharmaceutical distribution. The broad mechanics of the trade remain similar across markets, even though individual cities operate differently. More importantly, carrying the right products does not automatically secure business when numerous stockists can supply them.
Kunthunath Medical Agency responded by competing on the strength of the relationship surrounding the transaction. Viral spent considerable personal time with chemists and healthcare partners, learning their requirements and building familiarity before expecting business. That philosophy has matured with experience. In the early years, meeting a prospective customer meant looking immediately for a commercial opportunity. Today, the sequence has reversed: establish the relationship first and allow business to emerge from it.
It is a subtle shift, but one that has helped transform a network initially concentrated in Maharashtra and Gujarat into the foundation for national expansion.
A Five-Reference Filter before Procurement
Growth, however, creates another problem. A distributor expanding its customer base also needs broader procurement capabilities, and every new source introduces potential risk. For Kunthunath Medical Agency, this became particularly important because of the possibility of counterfeit or questionable medicines entering the supply chain. Rather than relying only on commercial assurances, the company introduced a practical supplier-screening SOP.
Before procuring from an unfamiliar supplier, the team asks for approximately five customer references. It then verifies the supplier's track record, the products supplied and market credibility before deciding whether to establish a procurement relationship. This process reflects a larger principle within the business: an attractive short-term purchase cannot justify a long-term credibility problem. After years of distributing ethical medicines from different companies, the business is preparing to establish its own pharmaceutical venture and introduce an own portfolio of products
“The company has consequently worked on both sides of its network. It invests in the suppliers from whom it procures as deliberately as it invests in the chemists and partners to whom it sells. Over time, selected vendors become dependable procurement relationships rather than interchangeable sources of stock," speaks Viral Shah, Managing Partner.
That becomes particularly relevant in healthcare, where distribution is not merely a goods transaction. A routine requirement can quickly become an urgent one. Availability and timely movement therefore become part of the distributor's service proposition, requiring coordination between procurement, inventory, people and partners.
Moving from Doing Everything to Building an Organization
Viral Shah's own role provides a useful picture of how Kunthunath Medical Agency has evolved. At the beginning, there was little separation between entrepreneur and operation. With a very small team, he purchased medicines, sold them, developed the market and handled everyday responsibilities himself.
As the team grew, responsibilities were separated and people were given defined roles. Delegating daily execution created room for Shah to examine new markets, procurement opportunities and avenues for national growth. Internally, clear communication and coordination became increasingly important because consistency could no longer depend on one individual's involvement. His engagement with the wider pharmaceutical community has developed in parallel. Viral Shah is National Secretary of the Jain Pharma Federation, a network with more than 900 members that he was involved in establishing. Expansion required him to stop being the center of every activity.
The Next Move: From Distributor to Product Owner
Kunthunath Medical Agency's next chapter could alter its position in the value chain. After years of distributing ethical medicines from different companies, the business is preparing to establish its own pharmaceutical venture and introduce an own portfolio of products.
“The move will allow it to apply years of learning from the distribution end of the market-what partners require, how products move, where procurement risks emerge and why some commercial relationships endure while others do not-to its own product journey,” shares Hardik Jain, Partner.
PAN-India expansion will continue alongside this transition, but Viral Shah's approach remains deliberately sequential: build the capability, protect the network and then scale it. For Kunthunath Medical Agency, the ambition is therefore not simply to place more medicines in more markets. It is to grow without losing the operating discipline that made those markets accessible in the first place.